These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 32109513)

  • 21. PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel.
    Zhang X; Lu J; Huang Y; Zhao W; Chen Y; Li J; Gao X; Venkataramanan R; Sun M; Stolz DB; Zhang L; Li S
    Bioconjug Chem; 2013 Mar; 24(3):464-72. PubMed ID: 23425093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-assembled nanoparticles from hyaluronic acid-paclitaxel prodrugs for direct cytosolic delivery and enhanced antitumor activity.
    Xu C; He W; Lv Y; Qin C; Shen L; Yin L
    Int J Pharm; 2015 Sep; 493(1-2):172-81. PubMed ID: 26232702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel cathepsin B-sensitive paclitaxel conjugate: Higher water solubility, better efficacy and lower toxicity.
    Liang L; Lin SW; Dai W; Lu JK; Yang TY; Xiang Y; Zhang Y; Li RT; Zhang Q
    J Control Release; 2012 Jun; 160(3):618-29. PubMed ID: 22410114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective tissue distribution and long circulation endowed by paclitaxel loaded PEGylated poly(ε-caprolactone-co-L-lactide) micelles leading to improved anti-tumor effects and low systematic toxicity.
    Wang F; Shen Y; Xu X; Lv L; Li Y; Liu J; Li M; Guo A; Guo S; Jin F
    Int J Pharm; 2013 Nov; 456(1):101-12. PubMed ID: 23968782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction-sensitive dual functional nanomicelles for improved delivery of paclitaxel.
    Zhang X; Liu K; Huang Y; Xu J; Li J; Ma X; Li S
    Bioconjug Chem; 2014 Sep; 25(9):1689-96. PubMed ID: 25121577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanomedicine-based paclitaxel induced apoptotic signaling pathways in A562 leukemia cancer cells.
    Wang Y; Zhou L; Xiao M; Sun ZL; Zhang CY
    Colloids Surf B Biointerfaces; 2017 Jan; 149():16-22. PubMed ID: 27716527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma Stability and Plasma Metabolite Concentration-Time Profiles of Oligo(Lactic Acid)
    Repp L; Skoczen SL; Rasoulianboroujeni M; Stern ST; Kwon GS
    AAPS J; 2023 Apr; 25(3):39. PubMed ID: 37041376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery.
    Wu Y; Chu Q; Tan S; Zhuang X; Bao Y; Wu T; Zhang Z
    Int J Nanomedicine; 2015; 10():5219-35. PubMed ID: 26316751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers.
    Lu J; Huang Y; Zhao W; Marquez RT; Meng X; Li J; Gao X; Venkataramanan R; Wang Z; Li S
    Biomaterials; 2013 Feb; 34(5):1591-600. PubMed ID: 23182923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transferrin receptor-targeted redox/pH-sensitive podophyllotoxin prodrug micelles for multidrug-resistant breast cancer therapy.
    Li Y; Chen M; Yao B; Lu X; Zhang X; He P; Vasilatos SN; Ren X; Bian W; Yao C
    J Mater Chem B; 2019 Oct; 7(38):5814-5824. PubMed ID: 31495855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle.
    Rezazadeh M; Emami J; Hasanzadeh F; Sadeghi H; Minaiyan M; Mostafavi A; Rostami M; Lavasanifar A
    Drug Deliv; 2016 Jun; 23(5):1707-17. PubMed ID: 25188785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma.
    Gong C; Xie Y; Wu Q; Wang Y; Deng S; Xiong D; Liu L; Xiang M; Qian Z; Wei Y
    Nanoscale; 2012 Sep; 4(19):6004-17. PubMed ID: 22910790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanoparticles Containing High Loads of Paclitaxel-Silicate Prodrugs: Formulation, Drug Release, and Anticancer Efficacy.
    Han J; Michel AR; Lee HS; Kalscheuer S; Wohl A; Hoye TR; McCormick AV; Panyam J; Macosko CW
    Mol Pharm; 2015 Dec; 12(12):4329-35. PubMed ID: 26505116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PEG-derivatized birinapant as a nanomicellar carrier of paclitaxel delivery for cancer therapy.
    Shu X; Zhu Z; Cao D; Zheng L; Wang F; Pei H; Wen J; Yang J; Li D; Bai P; Tang M; Ye H; Peng A; Li W; Chen L
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110356. PubMed ID: 31319226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.
    Jiang C; Wang H; Zhang X; Sun Z; Wang F; Cheng J; Xie H; Yu B; Zhou L
    Int J Pharm; 2014 Nov; 475(1-2):60-8. PubMed ID: 25152167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Core-crosslinked pH-sensitive degradable micelles: A promising approach to resolve the extracellular stability versus intracellular drug release dilemma.
    Wu Y; Chen W; Meng F; Wang Z; Cheng R; Deng C; Liu H; Zhong Z
    J Control Release; 2012 Dec; 164(3):338-45. PubMed ID: 22800578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study on the preparation and activity of intelligent response poly(lactic-co-glycolic acid)-ss-polyethylene glycol copolymer micelles.
    Wang S; Xie L; Liu Y; Yang Q; Jia W; Zhao D; Zhao X
    J Biomater Appl; 2022 Aug; 37(2):259-274. PubMed ID: 35533369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disulfide-crosslinked nanomicelles confer cancer-specific drug delivery and improve efficacy of paclitaxel in bladder cancer.
    Pan A; Zhang H; Li Y; Lin TY; Wang F; Lee J; Cheng M; Dall'Era M; Li T; deVere White R; Pan CX; Lam KS
    Nanotechnology; 2016 Oct; 27(42):425103. PubMed ID: 27640312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.
    Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J
    Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.